Clinical Trial Update: Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria [Phase 3]

View source ↗

Summary

This open-label Phase 3 study of uridine triacetate in pediatric patients with hereditary orotic aciduria has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Orotic Aciduria

Drugs mentioned

• Uridine Triacetate (uridine triacetate)

Snippet

Sponsor: Wellstat Therapeutics | Conditions: Hereditary Orotic Aciduria | Phase 3 | Status: COMPLETED | Results posted: 2017-06-28